These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9677334)

  • 1. Human thrombopoietin structure-function relationships: identification of functionally important residues.
    Jagerschmidt A; Fleury V; Anger-Leroy M; Thomas C; Agnel M; O'brien DP
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):729-34. PubMed ID: 9677334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of functionally important residues of human thrombopoietin.
    Park H; Park SS; Jin EH; Song JS; Ryu SE; Yu MH; Hong HJ
    J Biol Chem; 1998 Jan; 273(1):256-61. PubMed ID: 9417073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin.
    Porteu F; Rouyez MC; Cocault L; Bénit L; Charon M; Picard F; Gisselbrecht S; Souyri M; Dusanter-Fourt I
    Mol Cell Biol; 1996 May; 16(5):2473-82. PubMed ID: 8628315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of thrombopoietin for identification of receptor and neutralizing antibody sites.
    Pearce KH; Potts BJ; Presta LG; Bald LN; Fendly BM; Wells JA
    J Biol Chem; 1997 Aug; 272(33):20595-602. PubMed ID: 9252374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.
    Drachman JG; Kaushansky K
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2350-5. PubMed ID: 9122198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Mpl mutants using primary megakaryocyte-lineage cells from mpl(-/-) mice: a new system for Mpl structure-function studies.
    Gaur M; Murphy GJ; deSauvage FJ; Leavitt AD
    Blood; 2001 Mar; 97(6):1653-61. PubMed ID: 11238104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structure-function analysis of serine/threonine phosphorylation of the thrombopoietin receptor, c-Mpl.
    Miyakawa Y; Drachman JG; Gallis B; Kaushansky A; Kaushansky K
    J Biol Chem; 2000 Oct; 275(41):32214-9. PubMed ID: 10918061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.
    Rouyez MC; Boucheron C; Gisselbrecht S; Dusanter-Fourt I; Porteu F
    Mol Cell Biol; 1997 Sep; 17(9):4991-5000. PubMed ID: 9271377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology modeling of the receptor binding domain of human thrombopoietin.
    Song JS; Park H; Hong HJ; Yu MH; Ryu SE
    J Comput Aided Mol Des; 1998 Sep; 12(5):419-24. PubMed ID: 9834904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of active thrombopoietin and identification of its key residues responsible for receptor binding.
    Hou J; Zhan H
    Cytokine; 1998 May; 10(5):319-30. PubMed ID: 9619369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.
    Sabath DF; Lin N; Sabath DE; Kaushansky K; Broudy VC
    Cytokine; 2000 Feb; 12(2):127-33. PubMed ID: 10671297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
    Drexler HG; Quentmeier H
    Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
    Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
    Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin and the c-Mpl receptor: insights from gene targeting.
    Alexander WS
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MplK, a natural variant of the thrombopoietin receptor with a truncated cytoplasmic domain, binds thrombopoietin but does not interfere with thrombopoietin-mediated cell growth.
    Millot GA; Feger F; Garçon L; Vainchenker W; Dumenil D; Svinarchuk F
    Exp Hematol; 2002 Feb; 30(2):166-75. PubMed ID: 11823052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis.
    Rojnuckarin P; Drachman JG; Kaushansky K
    Blood; 1999 Aug; 94(4):1273-82. PubMed ID: 10438715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin induces an SH2-containing protein, CIS1, which binds to Mpl: involvement of the ubiquitin proteosome pathway.
    Okabe S; Tauchi T; Morita H; Ohashi H; Yoshimura A; Ohyashiki K
    Exp Hematol; 1999 Oct; 27(10):1542-7. PubMed ID: 10517496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways.
    Garcia J; de Gunzburg J; Eychène A; Gisselbrecht S; Porteu F
    Mol Cell Biol; 2001 Apr; 21(8):2659-70. PubMed ID: 11283246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.